Diabetes & Metabolism Journal
SGLT inhibitors for type 1 diabetes: a finely balanced matter?
SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control | Nature Reviews Cardiology
SGLT inhibitors: a novel target for diabetes | Pharmaceutical Patent Analyst
Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials | The BMJ
Typ-1-Diabetes
Combined SGLT1 and SGLT2 Inhibitors and Their Role in Diabetes Care | Diabetes Technology & Therapeutics
SGLT2 Inhibitors, GLP-1 Agonists, and DPP-4 Inhibitors in Diabetes and Microvascular Complications: A Review
24-week efficacy and safety of sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, as adjunct therapy to insulin in type 1 diabetes (inTandem2) - Media Centre | EASD
Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives | Cardiovascular Diabetology | Full Text
IJMS | Free Full-Text | Crosstalk between Sodium–Glucose Cotransporter Inhibitors and Sodium–Hydrogen Exchanger 1 and 3 in Cardiometabolic Diseases
Role and regulation of intestinal SGLT1 for glucose uptake and... | Download Scientific Diagram
SGLT2 Inhibitors – Diabetologia
Clinical Significance Of SGLT-2 | Our Biochemistry- Namrata Chhabra
The Na+‐D‐glucose cotransporters SGLT1 and SGLT2 are targets for the treatment of diabetes and cancer | Semantic Scholar
Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus. - Abstract - Europe PMC
Cureus | Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitors: Delving Into the Potential Benefits of Cardiorenal Protection Beyond the Treatment of Type-2 Diabetes Mellitus
Clinical Evidence and Proposed Mechanisms for Cardiovascular and Kidney Benefits from Sodium–Glucose Co-transporter-2 Inhibitors – touchENDOCRINOLOGY
Structural mechanism of SGLT1 inhibitors | Nature Communications
Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus. - Abstract - Europe PMC
SGLT Inhibitors
Antidiabetic Effects of a Tripeptide That Decreases Abundance of Na+-d-glucose Cotransporter SGLT1 in the Brush-Border Membrane of the Small Intestine | ACS Omega
Frontiers | New insights and advances of sodium-glucose cotransporter 2 inhibitors in heart failure
Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty L | DMSO
Kidney and Dialysis | Free Full-Text | The Pathophysiological Basis of Diabetic Kidney Protection by Inhibition of SGLT2 and SGLT1
